Phenotype of striatofugal medium spiny neurons in parkinsonian and dyskinetic nonhuman primates: A call for a reappraisal of the functional organization of the basal ganglia

Journal of Neuroscience

Volumn 26, Issue 34, 2006, Pages 8653-8661

  Nadjar, Agnes ^a   Brotchie, Jonathan M ^c,d   Guigoni, Celine ^a   Li, Qin ^e   Zhou, Shao Bo ^c   Wang, Gui Jie ^c   Ravenscroft, Paula ^c   Georges, François ^b   Crossman, Alan R ^c   Bezard, Erwan ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b INSERM   (France)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

Cholera toxin; Dopamine receptor; Dynorphin; Enkephalin; Globus pallidus; HPLC RIA; Immunohistochemistry; Striatum

Indexed keywords

BENSERAZIDE PLUS LEVODOPA; CHOLERA TOXIN B SUBUNIT; DOPAMINE RECEPTOR; DYNORPHIN; LEVODOPA; METENKEPHALIN; OPIATE PEPTIDE; SUBSTANCE P RECEPTOR; TRACER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASAL GANGLION; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DYSKINESIA; FEMALE; GLOBUS PALLIDUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; INJECTION SITE; NERVE CELL; NONHUMAN; PARKINSONISM; PHENOTYPE; PRIMATE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RADIOIMMUNOASSAY; STEREOTAXIS;

EID: 33748259615     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2582-06.2006     Document Type: Article

References (64)

1. Aizman O, Brismar H, Uhlen P, Zettergren E, Levey AI, Forssberg H, Greengard P, Aperia A (2000) Anatomical and physiological evidence for D-1 and D-2 dopamine receptor colocalization in neostriatal neurons. Nat Neurosci 3:226-230.
2. Akaike A, Ohno Y, Sasa M, Takaori S (1987) Excitatory and inhibitory effects of dopamine on neuronal activity of the caudate nucleus neurons in vitro. Brain Res 418:262-272.
3. Albin RL, Young AB, Penney JB (1995) The functional anatomy of disorders of the basal ganglia. Trends Neurosci 18:63-64.
4. Alexander GE, Crutcher MD (1990) Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 13:266-271.
5. Anderson KD, Reiner A (1991) Striatonigral projection neurons: a retrograde labeling study of the percentages that contain substance P or enkephalin in pigeons. J Comp Neurol 303:658-673.
6. Asselin MC, Soghomonian JJ, Côté PY, Parent A (1994) Striatal changes in preproenkephalin mRNA levels in parkinsonian monkeys. NeuroReport 5:2137-2140.
7. Aubert I, Ghorayeb I, Normand E, Bloch B (2000) Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum. J Comp Neurol 418:22-32.
8. Aubert I, Guigoni C, Hakansson K, Li Q, Dovero S, Barthe N, Bioulac BH, Gross CE, Fisone G, Bloch B, Bezard E (2005) Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia. Ann Neurol 57:17-26.
9. Aubert I, Guigoni C, Li Q, Dovero S, Bioulac BH, Gross CE, Crossman AR, Bloch B, Bezard E (2006) Enhanced preproenkephalin-B-derived opioid transmission in striatum and subthalamic nucleus converges upon globus pallidus internalis in L-dopa-induced dyskinesia. Biol Psychiatry, in press.
10. Augood SJ, Emson PC, Mitchell IJ, Boyce S, Clarke CE, Crossman AR (1989) Cellular localisation of enkephalin gene expression in MPTP-treated cynomolgus monkeys. Brain Res Mol Brain Res 6:85-92.
11. Beaumont A, Metters KM, Rossier J, Hughes J (1985) Identification of a proenkephalin precursor in striatal tissue. J Neurochem 44:934-940.
12. Bernard V, Laribi O, Levey AI, Bloch B (1998) Subcellular redistribution of m2 muscarinic acetylcholine receptors in striatal interneurons in vivo after acute cholinergic stimulation. J Neurosci 18:10207-10218.
13. Besson MJ, Graybiel AM, Quinn B (1990) Co-expression of neuropeptides in the cat's striatum: an immunohistochemical study of substance P, dynorphin B and enkephalin. Neuroscience 39:33-58.
14. Bezard E, Dovero S, Prunier C, Ravenscroft P, Chalon S, Guilloteau D, Bioulac B, Brotchie JM, Gross CE (2001) Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive MPTP-lesioned macaque model of Parkinson's disease. J Neurosci 21:6853-6861.
15. Bezard E, Ferry S, Mach U, Stark H, Leriche L, Boraud T, Gross CE, Sokoloff P (2003) Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function. Nat Med 9:762-767.
16. Bolam JP (1992) Preparation of central nervous system tissue for light and electron microscopy. In: Experimental neuroanatomy: a practical approach (Rickwood D, Hames BD, eds), pp 1-29. New York: Oxford UP.
17. Boundy VA, Luedtke RR, Artymyshyn RP, Filtz TM, Molinoff PB (1993) Development of polyclonal anti-D2 dopamine receptor antibodies using sequence-specific peptides. Mol Pharmacol 43:666-676.
18. Chen S, Aston-Jones G (1995) Evidence that cholera toxin B subunit (CTb) can be avidly taken up and transported by fibers of passage. Brain Res 674:107-111.
19. Civelli O, Douglass J, Goldstein A, Herbert E (1985) Sequence and expression of the rat prodynorphin gene. Proc Natl Acad Sci USA 82:4291-4295.
20. Day M, Wang Z, Ding J, An X, Ingham CA, Shering AF, Wokosin D, Ilijic E, Sun Z, Sampson AR, Mugnaini E, Deutch AY, Sesack SR, Arbuthnott GW, Surmeier DJ (2006) Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci 9:251-259.
21. 1 dopamine receptor in striatal neurons in vivo as evidence of activation by dopamine agonists. J Neurosci 18:1650-1661.
22. El Meskini R, Cline LB, Eipper BA, Ronnett GV (2005) The developmentally regulated expression of Menkes protein ATP7A suggests a role in axon extension and synaptogenesis. Dev Neurosci 27:333-348.
23. Féger J, Crossman AR (1984) Identification of different subpopulations of neostriatal neurones projecting to globus pallidus or substantia nigra in the monkey: a retrograde fluorescence double-labelling study. Neurosci Lett 49:7-12.
24. Fernandez A, de Ceballos ML, Jenner P, Marsden CD (1992) Striatal neuropeptide levels in Parkinson's disease patients. Neurosci Lett 145:171-174.
25. Fernandez A, de Ceballos ML, Rose S, Jenner P, Marsden CD (1996) Alterations in peptide levels in Parkinson's disease and incidental Lewy body disease. Brain 119:823-830.
26. Georges F, Aston-Jones G (2002) Activation of ventral tegmental area cells by the bed nucleus of the stria terminalis: a novel excitatory amino acid input to midbrain dopamine neurons. J Neurosci 22:5173-5187.
27. Gerfen CR, Young WS (1988) Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res 460:161-167.
28. Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJ, Sibley DR (1990) D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250:1429-1432.
29. Guigoni C, Dovero S, Aubert I, Li Q, Bioulac BH, Bloch B, Gurevich EV, Gross CE, Bezard E (2005) Levodopa-induced dyskinesia in MPTP-treated macaques is not dependent on the extent and pattern of nigrostrial lesioning. Eur J Neurosci 22:283-287.
30. Harrison MB, Wiley RG, Wooten GF (1990) Selective localization of striatal D1 receptors to striatonigral neurons. Brain Res 528:317-322.
31. Hazrati LN, Parent A (1992) Differential patterns of arborization of striatal and subthalamic fibers in the two pallidal segments in primates. Brain Res 598:311-315.
32. Henry B, Duty S, Fox SH, Crossman AR, Brotchie JM (2003) Increased striatal pre-proenkephalin B expression is associated with dyskinesia in Parkinson's disease. Exp Neurol 183:458-468.
33. Herrero MT, Augood SJ, Hirsch EC, Javoy-Agid F, Luquin MR, Agid Y, Obeso JA, Emson PC (1995) Effects of L-dopa on preproenkephalin and pre-protachykinin gene expression in the MPTP-treated monkey striatum. Neuroscience 68:1189-1198.
34. 2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents. J Neurosci 15:5222-5237.
35. Ingham CA, Hood SH, Taggart P, Arbuthnott GW (1998) Plasticity of synapses in the rat neostriatum after unilateral lesion of the nigrostriatal dopaminergic pathway. J Neurosci 18:4732-4743.
36. Jaber M, Dumartin B, Sagne C, Haycock JW, Roubert C, Giros B, Bloch B, Caron MG (1999) Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter. Eur J Neurosci 11:3499-3511.
37. Jolkkonen J, Jenner P, Marsden CD (1995) L-DOPA reverses altered gene expression of substance P but not enkephalin in the caudate-putamen of common marmosets treated with MPTP. Mol Brain res 32:297-307.
38. Jones NM, Bergeron M (2004) Hypoxia-induced ischemic tolerance in neonatal rat brain involves enhanced ERK1/2 signaling. J Neurochem 89:157-167.
39. Le Moine C, Bloch B (1995) D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J Comp Neurol 355:418-426.
40. Levesque M, Parent A (2005) The striatofugal fiber system in primates: a reevaluation of its organization based on single-axon tracing studies. Proc Natl Acad Sci USA 102:11888-11893.
41. Levey AI, Hersch SM, Rye DB, Sunahara RK, Niznik HB, Kitt CA, Price DL, Maggio R, Brann MR, Ciliax BJ (1993) Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies. Proc Natl Acad Sci USA 90:8861-8865.
42. Martin RF, Bowden DM (1996) A stereotaxic template atlas of the macaque brain for digital imaging and quantitative neuroanatomy. NeuroImage 4:119-150.
43. Mengual E, Pickel VM (2002) Ultrastructural immunocytochemical localization of the dopamine D2 receptor and tyrosine hydroxylase in the rat ventral pallidum. Synapse 43:151-162.
44. 2 agonist U91356A in continuous or intermittent mode of administration: comparison with L-dopa therapy. Mol Brain Res 49:55-62.
45. Morissette M, Grondin R, Goulet M, Bedard PJ, Di Paolo T (1999) Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D-1 or D-2 receptor agonists. J Neurochem 72:682-692.
46. Moritoyo T, Izumo S, Moritoyo H, Tanaka Y, Kiyomatsu Y, Nagai M, Usuku K, Sorimachi M, Osame M (1999) Detection of human T-lymphotropic virus type I p40tax protein in cerebrospinal fluid cells from patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. J Neurovirol 5:241-248.
47. Mushiake H, Inase M, Tanji J (1991) Neuronal activity in the primate premotor, supplementary, and precentral motor cortex during visually guided and internally determined sequential movements. J Neurophysiol 66:705-718.
48. Nadjar A, Combe C, Busquet P, Dantzer R, Parnet P (2005) Signaling pathways of interleukin-1 actions in the brain: anatomical distribution of phospho-ERK1/2 in the brain of rat treated systemically with interleukin-1beta. Neuroscience 134:921-932.
49. Ohno Y, Sasa M, Takaori S (1987) Coexistence of inhibitory dopamine D-1 and excitatory D-2 receptors on the same caudate nucleus neurons. Life Sci 40:1937-1945.
50. Parent A, Hazrati LN (1994) Multiple striatal representation in primate substantia nigra. J Comp Neurol 344:305-320.
51. Parent A, Hazrati LN (1995) Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Brain Res Rev 20:91-127.
52. Parent A, Bouchard C, Smith Y (1984) The striatopallidal and striatonigral projections: two distinct fiber systems in primate. Brain Res 303:385-390.
53. Parent A, Smith Y, Filion M, Dumas J (1989) Distinct afferents to internal and external pallidal segments in the squirrel monkey. Neurosci Lett 96:140-144.
54. Parent A, Charara A, Pinault D (1995) Single striatofugal axons arborizing in both pallidal segments and in the substantia nigra in primates. Brain Res 698:280-284.
55. Penny GR, Afsharpour S, Kitai ST (1986) The glutamate decarboxylase-, leucine enkephalin-, methionine enkephalin-andsubstance P-immunoreactive neurons in the neostriatum of the rat and cat: evidence for partial population overlap. Neuroscience 17:1011-1045.
56. Qvigstad G, Qvigstad T, Westre B, Sandvik AK, Brenna E, Waldum HL (2002) Neuroendocrine differentiation in gastric adenocarcinomas associated with severe hypergastrinemia and/or pernicious anemia. Apmis 110:132-139.
57. Selemon LD, Goldman-Rakic PS (1990) Topographic intermingling of striatonigral and striatopallidal neurons in the rhesus monkey. J Comp Neurol 297:359-376.
58. Seppanen O, Glumoff V, Paananen R, Rounioja S, Hallman M (2005) Transcription factors NF-kappaB and C/EBPdelta and IL-1-induced expression of surfactant protein A in lung explants during the perinatal period. Biol Neonate 87:152-159.
59. Stephens B, Mueller AJ, Shering AF, Hood SH, Taggart P, Arbuthnott GW, Bell JE, Kilford L, Kingsbury AE, Daniel SE, Ingham CA (2005) Evidence of a breakdown of corticostriatal connections in Parkinson's disease. Neuroscience 132:741-754.
60. Surmeier DJ, Song W-J, Yan Z (1996) Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. J Neurosci 16:6579-6591.
61. Tel BC, Zeng BY, Cannizzaro C, Pearce RK, Rose S, Jenner P (2002) Alterations in striatal neuropeptide mRNA produced by repeated administration of L-DOPA, ropinirole or bromocriptine correlate with dyskinesia induction in MPTP-treated common marmosets. Neuroscience 115:1047-1058.
62. Wang H, Pickel VM (2002) Dopamine D2 receptors are present in prefrontal cortical afferents and their targets in patches of the rat caudate-putamen nucleus. J Comp Neurol 442:392-404.
63. Wang HB, Laverghetta AV, Foehring R, Deng YP, Sun Z, Yamamoto K, Lei WL, Jiao Y, Reiner A (2006) Single-cell RT-PCR, in situ hybridization histochemical, and immunohistochemical studies of substance P and enkephalin co-occurrence in striatal projection neurons in rats. J Chem Neuroanat 31:178-199.
64. Zachariou V, Sgambato-Faure V, Sasaki T, Svenningsson P, Berton O, Fienberg AA, Nairn AC, Greengard P, Nestler EJ (2006) Phosphorylation of DARPP-32 at threonine-34 is required for cocaine action. Neuropsychopharmacology 31:555-562.